Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors.
carrier testing
health equity
population screening
preconception
risk assessment
Journal
Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
20
12
2022
received:
08
02
2022
accepted:
23
12
2022
medline:
14
6
2023
pubmed:
10
2
2023
entrez:
9
2
2023
Statut:
ppublish
Résumé
Expanded carrier screening (ECS) intends to broadly screen healthy individuals to determine their reproductive chance for autosomal recessive (AR) and X-linked (XL) conditions with infantile or early-childhood onset, which may impact reproductive management (Committee Opinion 690, Obstetrics and Gynecology, 2017, 129, e35). Compared to ethnicity-based screening, which requires accurate knowledge of ancestry for optimal test selection and appropriate risk assessment, ECS panels consist of tens to hundreds of AR and XL conditions that may be individually rare in various ancestries but offer a comprehensive approach to inherited disease screening. As such, the term "equitable carrier screening" may be preferable. This practice guideline provides evidence-based recommendations for ECS using the GRADE Evidence to Decision framework (Guyatt et al., BMJ, 2008, 336, 995; Guyatt et al., BMJ, 2008, 336, 924). We used evidence from a recent systematic evidence review (Ramdaney et al., Genetics in Medicine, 2022, 20, 374) and compiled data from peer-reviewed literature, scientific meetings, and clinical experience. We defined and prioritized the outcomes of informed consent, change in reproductive plans, yield in identification of at-risk carrier pairs/pregnancies, perceived barriers to ECS, amount of provider time spent, healthcare costs, frequency of severely/profoundly affected offspring, incidental findings, uncertain findings, patient satisfaction, and provider attitudes. Despite the recognized barriers to implementation and change in management strategies, this analysis supported implementation of ECS for these outcomes. Based upon the current level of evidence, we recommend ECS be made available for all individuals considering reproduction and all pregnant reproductive pairs, as ECS presents an ethnicity-based carrier screening alternative which does not rely on race-based medicine. The final decision to pursue carrier screening should be directed by shared decision-making, which takes into account specific features of patients as well as their preferences and values. As a periconceptional reproductive risk assessment tool, ECS is superior compared to ethnicity-based carrier screening in that it both identifies more carriers of AR and XL conditions as well as eliminates a single race-based medical practice. ECS should be offered to all who are currently pregnant, considering pregnancy, or might otherwise biologically contribute to pregnancy. Barriers to the broad implementation of and access to ECS should be identified and addressed so that test performance for carrier screening will not depend on social constructs such as race.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
540-557Informations de copyright
© 2023 National Society of Genetic Counselors.
Références
Adashi, E. Y., & Dean, L. A. (2016). Access to and use of infertility services in the United States: Framing the challenges. Fertility and Sterility, 105(5), 1113-1118. https://doi.org/10.1016/j.fertnstert.2016.01.017
Akler, G., Birch, A. H., Schreiber-Agus, N., Cai, X., Cai, G., Shi, L., Yu, C., Larmore, A. M., Mendiratta-Vij, G., Elkhoury, L., Dillon, M. W., Zhu, J., Mclellan, A. S., Suer, F. E., Webb, B. D., Schadt, E. E., Kornreich, R., & Edelmann, L. (2020). Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients. Molecular Genetics & Genomic Medicine, 8(2), e1053. https://doi.org/10.1002/mgg3.1053
Arjunan, A., Bellerose, H., Torres, R., Ben-Shachar, R., Hoffman, J. D., Angle, B., Slotnick, R. N., Simpson, B. N., Lewis, A. M., Magoulas, P. L., Bontempo, K., Schulze, J., Tarpinian, J., Bucher, J. A., Dineen, R., Goetsch, A., Lazarin, G. A., & Johansen Taber, K. (2020). Evaluation and classification of severity for 176 genes on an expanded carrier screening panel. Prenatal Diagnosis, 40(10), 1246-1257. https://doi.org/10.1002/pd.5762
Arjunan, A., Torres, R., Gardiner, A., Kaseniit, K. E., Wootton, J., Ben-Shachar, R., & Johansen Taber, K. (2021). Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples. Prenatal Diagnosis, 41(7), 896-904. https://doi.org/10.1002/pd.5900
Beauchamp, K. A., Johansen Taber, K. A., & Muzzey, D. (2019). Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen. Genetics in Medicine, 21(9), 1948-1957. https://doi.org/10.1038/s41436-019-0455-8
Benn, P., Chapman, A. R., Erickson, K., Defrancesco, M. S., Wilkins-Haug, L., Egan, J. F., & Schulkin, J. (2014). Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenatal Diagnosis, 34(2), 145-152. https://doi.org/10.1002/pd.4272
Ben-Shachar, R., Svenson, A., Goldberg, J. D., & Muzzey, D. (2019). A data-driven evaluation of the size and content of expanded carrier screening panels. Genetics in Medicine, 21(9), 1931-1939. https://doi.org/10.1038/s41436-019-0466-5
Boardman, F. K. (2021). Attitudes toward population screening among people living with Fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his Fragile X syndrome away'. Journal of Genetic Counseling, 30(1), 85-97. https://doi.org/10.1002/jgc4.1355
Boardman, F. K., & Hale, R. (2018). How do genetically disabled adults view selective reproduction? Impairment, identity, and genetic screening. Molecular Genetics & Genomic Medicine, 6(6), 941-956. https://doi.org/10.1002/mgg3.463
Briggs, A., Nouri, P. K., Galloway, M., O'Leary, K., Pereira, N., & Lindheim, S. R. (2018). Expanded carrier screening: A current survey of physician utilization and attitudes. Journal of Assisted Reproduction and Genetics, 35(9), 1631-1640. https://doi.org/10.1007/s10815-018-1272-8
Bristow, S. L., Morris, J. M., Peyser, A., Gamma, A., Singer, T., Mullin, C., Onel, K., & Hershlag, A. (2019). Choosing an expanded carrier screening panel: Comparing two panels at a single fertility centre. Reproductive Biomedicine Online, 38(2), 225-232. https://doi.org/10.1016/j.rbmo.2018.11.018
Chokoshvili, D., Vears, D. F., & Borry, P. (2017). Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers. Best Practice & Research Clinical Obstetrics & Gynaecology, 44, 57-67. https://doi.org/10.1016/j.bpobgyn.2017.02.006
Clarke, E. V., Schneider, J. L., Lynch, F., Kauffman, T. L., Leo, M. C., Rosales, A. G., Dickerson, J. F., Shuster, E., Wilfond, B. S., & Goddard, K. (2018). Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. PLoS One, 13(7), e0200139. https://doi.org/10.1371/journal.pone.0200139
Committee Opinion No. 690. (2017). Carrier screening in the age of genomic medicine. Obstetrics and Gynecology, 129(3), e35-e40. https://doi.org/10.1097/AOG.0000000000001951
Conijn, T., Nijmeijer, S., Lakeman, P., Henneman, L., Wijburg, F. A., & Haverman, L. (2021). Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes. Journal of Genetic Counseling, 30(2), 457-469. https://doi.org/10.1002/jgc4.1332
de Wert, G., van der Hout, S., Goddijn, M., Vassena, R., Frith, L., Vermeulen, N., Eichenlaub-Ritter, U., & ESHRE Ethics Committee. (2021). The ethics of preconception expanded carrier screening in patients seeking assisted reproduction. Human Reproduction Open, 2021(1), hoaa063. https://doi.org/10.1093/hropen/hoaa063
Derderian, S. C., Jeanty, C., Walters, M. C., Vichinsky, E., & MacKenzie, T. C. (2015). In utero hematopoietic cell transplantation for hemoglobinopathies. Frontiers in Pharmacology, 5, 278. https://doi.org/10.3389/fphar.2014.00278
Dugger, C., Anderson, H., Miller, C. E., Wong, B., Johnson, E. P., & Rothwell, E. (2021). Assessing clinical education tools for expanded carrier screening. Journal of Genetic Counseling, 30(2), 606-615. https://doi.org/10.1002/jgc4.1349
Durieu, I., Dalon, F., Reynaud, Q., Lemonnier, L., Dehillotte, C., Bérard, M., Walther, D., Viprey, M., Van Ganse, E., & Belhassen, M. (2022). Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 88-95. https://doi.org/10.1016/j.jcf.2021.03.025
Dwan, M., Gannaway, R., Lucidi, R., & Jewell, A. (2019). Reproductive endocrinologists' utilization of genetic counselors and their services: Is there an unmet need? [conference presentation abstract]. National Society of genetic counselors (NSGC) 38th annual conference, Salt Lake City, UT, United States. https://app.core-apps.com/nsgc_ac2019/abstract/de549db9e9b29a95956277e0671b347f
Early, M. L., Kumar, P., Marcell, A. V., Lawson, C., Christianson, M., & Pecker, L. H. (2020). Literacy assessment of preimplantation genetic patient education materials exceed national reading levels. Journal of Assisted Reproduction and Genetics, 37(8), 1913-1922. https://doi.org/10.1007/s10815-020-01837-z
Easteal, S., Arkell, R. M., Balboa, R. F., Bellingham, S. A., Brown, A. D., Calma, T., Cook, M. C., Davis, M., Dawkins, H., Dinger, M. E., Dobbie, M. S., Farlow, A., Gwynne, K. G., Hermes, A., Hoy, W. E., Jenkins, M. R., Jiang, S. H., Kaplan, W., Leslie, S., … Baynam, G. (2020). Equitable expanded carrier screening needs indigenous clinical and population genomic data. American Journal of Human Genetics, 107(2), 175-182. https://doi.org/10.1016/j.ajhg.2020.06.005
Edwards, J. G., Feldman, G., Goldberg, J., Gregg, A. R., Norton, M. E., Rose, N. C., Schneider, A., Stoll, K., Wapner, R., & Watson, M. S. (2015). Expanded carrier screening in reproductive medicine-points to consider: A joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstetrics and Gynecology, 125(3), 653-662. https://doi.org/10.1097/AOG.0000000000000666
Elliott, J. H., Turner, T., Clavisi, O., Thomas, J., Higgins, J. P., Mavergames, C., & Gruen, R. L. (2014). Living systematic reviews: An emerging opportunity to narrow the evidence-practice gap. PLoS Medicine, 11(2), e1001603. https://doi.org/10.1371/journal.pmed.1001603
Fan, C. W., Castonguay, L., Rummell, S., Lévesque, S., Mitchell, J. J., & Sillon, G. (2018). Online module for carrier screening in Ashkenazi Jewish individuals compared with In-person genetics education: A randomized controlled trial. Journal of Genetic Counseling, 27(2), 426-438. https://doi.org/10.1007/s10897-017-0133-4
Fecteau, H., Duld, C., Tahmassi, A., Kamireddi, N., & Carlson, R. (2019). Quality and quantity: Outcome of whole gene sequencing in expanded carrier screening of routine preconception and prenatal female patients [conference presentation abstract]. National Society of Genetic Counselors (NSGC) 38th annual conference, Salt Lake City, UT, United States. https://app.core-apps.com/nsgc_ac2019/abstract/de549db9e9b29a95956277e06711209e
Franasiak, J. M., Olcha, M., Bergh, P. A., Hong, K. H., Werner, M. D., Forman, E. J., Zimmerman, R. S., & Scott, R. T., Jr. (2016). Expanded carrier screening in an infertile population: How often is clinical decision making affected? Genetics in Medicine, 18(11), 1097-1101. https://doi.org/10.1038/gim.2016.8
Ghiossi, C. E., Goldberg, J. D., Haque, I. S., Lazarin, G. A., & Wong, K. K. (2018). Clinical utility of expanded carrier screening: Reproductive behaviors of at-risk couples. Journal of Genetic Counseling, 27(3), 616-625. https://doi.org/10.1007/s10897-017-0160-1
Giles Choates, M., Stevens, B. K., Wagner, C., Murphy, L., Singletary, C. N., & Wittman, A. T. (2020). It takes two: Uptake of carrier screening among male reproductive partners. Prenatal Diagnosis, 40(3), 311-316. https://doi.org/10.1002/pd.5588
Goodhue, B., Denton, J., Newman, R., Salmon, J., & Dudek, M. (2019). The effect of an educational video on knowledge and intent in an OB/GYN population [conference presentation abstract]. National Society of Genetic Counselors (NSGC) 38th annual conference, Salt Lake City, UT, United States. https://app.core-apps.com/nsgc_ac2019/abstract/de549db9e9b29a95956277e06718c898
Gregg, A. R., Aarabi, M., Klugman, S., Leach, N. T., Bashford, M. T., Goldwaser, T., Chen, E., Sparks, T. N., Reddi, H. V., Rajkovic, A., Dungan, J. S., Professional Practice, A. C. M. G., & Committee, G. (2021). Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 23, 1793-1806. https://doi.org/10.1038/s41436-021-01203-z
Grinzaid, K. A., Page, P. Z., Denton, J. J., & Ginsberg, J. (2015). Creation of a national, at-home model for Ashkenazi Jewish carrier screening. Journal of Genetic Counseling, 24(3), 381-387. https://doi.org/10.1007/s10897-014-9800-x
Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., & Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening. Genetics in Medicine, 15(6), 482-483. https://doi.org/10.1038/gim.2013.47
Guo, M. H., & Gregg, A. R. (2019). Estimating yields of prenatal carrier screening and implications for design of expanded carrier screening panels. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 21(9), 1940-1947. https://doi.org/10.1038/s41436-019-0472-7
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., DeBeer, H., Jaeschke, R., Rind, D., Meerpohl, J., Dahm, P., & Schünemann, H. J. (2011). GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, 64(4), 383-394. https://doi.org/10.1016/j.jclinepi.2010.04.026
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., Schünemann, H. J., & GRADE Working Group. (2008). What is "quality of evidence" and why is it important to clinicians? BMJ, 336(7651), 995-998. https://doi.org/10.1136/bmj.39490.551019.BE
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., Schünemann, H. J., & GRADE Working Group. (2008). GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924-926. https://doi.org/10.1136/bmj.39489.470347.AD
Harbison, A., Terhaar, C., Swope, B., Settler, C., Dohany, L., Holland, C., DaRe, J., Longman, R., & Niemchak, T. (2017). Identifying unexpected carriers with expanded pan-ethnic carrier testing. Poster abstracts of the ISPD 21st international conference on prenatal diagnosis and therapy, San Diego, California, USA, 9-12 July 2017. Prenatal Diagnosis, 37(Suppl. 1), 21-105.
Hardy, M. W., Kener, H. J., & Grinzaid, K. A. (2018). Implementation of a carrier screening program in a high-risk undergraduate student population using digital marketing, online education, and telehealth. Public Health Genomics, 21(1-2), 67-76. https://doi.org/10.1159/000493971
Held, P. K., Rice, G. M., Kuhl, A., Drilias, N., Baker, M., Deline, J., Spicer, G., Sandrock, C., Seroogy, C. M., & Schwoerer, J. S. (2019). Newborn screening for inherited metabolic disorders: Early identification and long-term care for patients in the Plain community, Wisconsin, 2011-2017. Public Health Reports (Washington, D.C.: 1974), 134(2_suppl), 58S-63S. https://doi.org/10.1177/0033354919878425
Henneman, L., Borry, P., Chokoshvili, D., Cornel, M. C., van El, C. G., Forzano, F., Hall, A., Howard, H. C., Janssens, S., Kayserili, H., Lakeman, P., Lucassen, A., Metcalfe, S. A., Vidmar, L., de Wert, G., Dondorp, W. J., & Peterlin, B. (2016). Responsible implementation of expanded carrier screening. European Journal of Human Genetics: EJHG, 24(6), e1-e12. https://doi.org/10.1038/ejhg.2015.271
Johansen Taber, K. A., Beauchamp, K. A., Lazarin, G. A., Muzzey, D., Arjunan, A., & Goldberg, J. D. (2019). Clinical utility of expanded carrier screening: Results-guided actionability and outcomes. Genetics in Medicine, 21(5), 1041-1048. https://doi.org/10.1038/s41436-018-0321-0
Jurgensmeyer, S., Walterman, S., Wagner, A., Wong, K., Bao, A., Stueber, S., & Spencer, S. (2021). Female and male perspectives on male partner roles in expanded carrier screening. Journal of Assisted Reproduction and Genetics, 38(2), 375-385. https://doi.org/10.1007/s10815-020-02029-5
Kaseniit, K. E., Haque, I. S., Goldberg, J. D., Shulman, L. P., & Muzzey, D. (2020). Genetic ancestry analysis on >93,000 individuals undergoing expanded carrier screening reveals limitations of ethnicity-based medical guidelines. Genetics in Medicine, 22(10), 1694-1702. https://doi.org/10.1038/s41436-020-0869-3
Kawwass, J. F., Penzias, A. S., & Adashi, E. Y. (2021). Fertility - a human right worthy of mandated insurance coverage: The evolution, limitations, and future of access to care. Fertility and Sterility, 115(1), 29-42. https://doi.org/10.1016/j.fertnstert.2020.09.155
Kuhl, A., van Calcar, S., Baker, M., Seroogy, C. M., Rice, G., & Scott Schwoerer, J. (2017). Development of carrier testing for common inborn errors of metabolism in the Wisconsin Plain population. Genetics in Medicine, 19(3), 352-356. https://doi.org/10.1038/gim.2016.104
Larsen, D., Ma, J., Strassberg, M., Ramakrishnan, R., & Van den Veyver, I. B. (2019). The uptake of pan-ethnic expanded carrier screening is higher when offered during preconception or early prenatal genetic counseling. Prenatal Diagnosis, 39(4), 319-323. https://doi.org/10.1002/pd.5434
Lazarin, G. A., Hawthorne, F., Collins, N. S., Platt, E. A., Evans, E. A., & Haque, I. S. (2014). Systematic classification of disease severity for evaluation of expanded carrier screening panels. PLoS One, 9(12), e114391. https://doi.org/10.1371/journal.pone.0114391
Le Clerc-Blain, J., Gosselin, V., Bearskin, A., Torrie, J. E., Mitchell, G. A., Wilson, B. J., Richter, A., & Laberge, A. M. (2019). High school carrier screening: Feelings and attitudes of students in Cree communities [conference presentation abstract]. National Society of Genetic Counselors (NSGC) 38th annual conference, Salt Lake City, UT, United States. https://app.core-apps.com/nsgc_ac2019/abstract/de549db9e9b29a95956277e06711d7ad
Lynch, F. L., Himes, P., Gilmore, M. J., Morris, E. M., Schneider, J. L., Kauffman, T. L., Shuster, E., Reiss, J. A., Dickerson, J. F., Leo, M. C., Davis, J. V., McMullen, C. K., Wilfond, B. S., & Goddard, K. (2018). Time costs for genetic counseling in preconception carrier screening with genome sequencing. Journal of Genetic Counseling, 27(4), 823-833. https://doi.org/10.1007/s10897-017-0205-5
Mathijssen, I. B., Holtkamp, K., Ottenheim, C., van Eeten-Nijman, J., Lakeman, P., Meijers-Heijboer, H., van Maarle, M. C., & Henneman, L. (2018). Preconception carrier screening for multiple disorders: Evaluation of a screening offer in a Dutch founder population. European Journal of Human Genetics: EJHG, 26(2), 166-175. https://doi.org/10.1038/s41431-017-0056-4
Molster, C. M., Lister, K., Metternick-Jones, S., Baynam, G., Clarke, A. J., Straub, V., Dawkins, H. J., & Laing, N. (2017). Outcomes of an international workshop on preconception expanded carrier screening: Some considerations for governments. Frontiers in Public Health, 5, 25. https://doi.org/10.3389/fpubh.2017.00025
Moore, R. A., Matthews, A. L., & Cohen, L. (2018). How might the genetics profession better utilize social media. Journal of Genetic Counseling, 27(2), 493-504. https://doi.org/10.1007/s10897-018-0215-y
National Society of Genetic Counselors Evidence-Based Clinical Practice Guideline Development Manual (A Living Document). (2020). https://www.nsgc.org/Portals/0/Docs/NSGC%20PG%20Manual%20Revision%20-%20March%202020.pdf
Neitzel, D., Leahey, L., Glass, S., & Faulkner, N. (2019). Carrier screening in 2019: Expanded panels are on the rise [conference presentation abstract]. National Society of Genetic Counselors (NSGC) 38th annual conference, Salt Lake City, UT, United States. https://app.core-apps.com/nsgc_ac2019/abstract/de549db9e9b29a95956277e067159f26
Nesbit, C. B., Pollack, C. C., Mascia, N. S., LaCroix, V. H., Applebee, D. M., Bosco, A. W., Wilkinson-Ryan, I., Erekson, E. D., & Evans, R. H. (2021). Interest in and uptake of genetic counseling for preconception carrier screening when offered to predominantly white reproductive-age persons seeking gynecologic care at a single U.S. academic medical center. Journal of Genetic Counseling, 31, 109-119. https://doi.org/10.1002/jgc4.1457
Peyser, A., Singer, T., Mullin, C., Bristow, S. L., Gamma, A., Onel, K., & Hershlag, A. (2019). Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates. Genetics in Medicine, 21(6), 1400-1406. https://doi.org/10.1038/s41436-018-0331-y
Punj, S., Akkari, Y., Huang, J., Yang, F., Creason, A., Pak, C., Potter, A., Dorschner, M. O., Nickerson, D. A., Robertson, P. D., Jarvik, G. P., Amendola, L. M., Schleit, J., Simpson, D. K., Rope, A. F., Reiss, J., Kauffman, T., Gilmore, M. J., Himes, P., … Richards, C. S. (2018). Preconception carrier screening by genome sequencing: Results from the clinical laboratory. American Journal of Human Genetics, 102(6), 1078-1089. https://doi.org/10.1016/j.ajhg.2018.04.004
Ramdaney, A., Dunn, D. M., Weiss, R. B., & Rose, N. C. (2018). Beware the laboratory report: Discrepancy in variant classification on reproductive carrier screening. Genetics in Medicine, 20(3), 374-375. https://doi.org/10.1038/gim.2017.174
Ramdaney, A., Lichten, L., Propst, L., Mann, C., Lazarin, G. A., Jones, M., Taylor, A., & Malinowski, J. (2022). Exploration of patient and provider impact of expanded carrier screening in the United States: A systematic evidence review. Journal of Genetic Counseling, 31, 937-948. https://doi.org/10.1002/jgc4.1566
Reed, E. K., Johansen Taber, K. A., Ingram Nissen, T., Schott, S., Dowling, L. O., O'Leary, J. C., & Scott, J. A. (2016). What works in genomics education: Outcomes of an evidenced-based instructional model for community-based physicians. Genetics in Medicine, 18(7), 737-745. https://doi.org/10.1038/gim.2015.144
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & Laboratory Quality Assurance Committee, A. C. M. G. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Rothwell, E., Johnson, E., Mathiesen, A., Golden, K., Metcalf, A., Rose, N. C., & Botkin, J. R. (2017). Experiences among women with positive prenatal expanded carrier screening results. Journal of Genetic Counseling, 26(4), 690-696. https://doi.org/10.1007/s10897-016-0037-8
Saucier, J., Westemeyer, M., Walker, J., Rakova, I., & Leonard, S. (2019). Expanded carrier screening for inborn errors of metabolism: Valuable early information [conference presentation abstract]. International Society for Prenatal Diagnosis 23rd international conference on prenatal diagnosis and Therapy, Singapore. https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pd.5625
Shapiro, A. J., Kroener, L., & Quinn, M. M. (2021). Expanded carrier screening for recessively inherited disorders: Economic burden and factors in decision-making when one individual in a couple is identified as a carrier. Journal of Assisted Reproduction and Genetics, 38(4), 957-963. https://doi.org/10.1007/s10815-021-02084-6
Shapiro, A. J., & Quinn, M. M. (2020). Patient experience with expanded-carrier screening: Adequacy of provider counseling, economic burden and decision-making regarding partner testing [conference presentation abstract]. American Society for Reproductive Medicine Scientific Congress & Expo, Virtual Congress. https://www.fertstert.org/article/S0015-0282(20)30834-7/fulltext
Simone, L., Khan, S., Ciarlariello, M., Lin, J., Trackman, S., Heiman, G. A., & Ashkinadze, E. (2021). Reproductive male partner testing when the female is identified to be a genetic disease carrier. Prenatal Diagnosis, 41(1), 21-27. https://doi.org/10.1002/pd.5824
Strom, C. M., Crossley, B., Buller-Buerkle, A., Jarvis, M., Quan, F., Peng, M., Muralidharan, K., Pratt, V., Redman, J. B., & Sun, W. (2011). Cystic fibrosis testing 8 years on: Lessons learned from carrier screening and sequencing analysis. Genetics in Medicine, 13(2), 166-172. https://doi.org/10.1097/GIM.0b013e3181fa24c4
Tardif, J., Pratte, A., & Laberge, A. M. (2018). Experience of carrier couples identified through a population-based carrier screening pilot program for four founder autosomal recessive diseases in Saguenay-Lac-Saint-Jean. Prenatal Diagnosis, 38(1), 67-74. https://doi.org/10.1002/pd.5055
Terry, S. F., & Bonhomme, N. (2013). Nothing about us without us: Guidelines for genetic testing. Genetic Testing and Molecular Biomarkers, 17(5), 357-358. https://doi.org/10.1089/gtmb.2013.1544
Thomas, L. A., Lewis, S., Massie, J., Kirk, E. P., Archibald, A. D., Barlow-Stewart, K., Boardman, F. K., Halliday, J., McClaren, B., & Delatycki, M. B. (2020). Which types of conditions should be included in reproductive genetic carrier screening? Views of parents of children with a genetic condition. European Journal of Medical Genetics, 63(12), 104075. https://doi.org/10.1016/j.ejmg.2020.104075
U.S. Census Bureau. (2022). Quick facts. U.S. Department of Commerce. https://www.census.gov/quickfacts/fact/table/US/IPE120219#IPE120219
van der Hout, S., Dondorp, W., & de Wert, G. (2019). The aims of expanded universal carrier screening: Autonomy, prevention, and responsible parenthood. Bioethics, 33(5), 568-576. https://doi.org/10.1111/bioe.12555
van der Hout, S., Holtkamp, K. C., Henneman, L., de Wert, G., & Dondorp, W. J. (2016). Advantages of expanded universal carrier screening: What is at stake? European Journal of Human Genetics: EJHG, 25(1), 17-21. https://doi.org/10.1038/ejhg.2016.125
Van Steijvoort, E., Chokoshvili, D., Cannon, J. W., Peeters, H., Peeraer, K., Matthijs, G., & Borry, P. (2020). Interest in expanded carrier screening among individuals and couples in the general population: Systematic review of the literature. Human Reproduction Update, 26(3), 335-355. https://doi.org/10.1093/humupd/dmaa001
Wei, S., Quigg, M. H., & Monaghan, K. G. (2007). Is cystic fibrosis carrier screening cost effective? Community Genetics, 10(2), 103-109. https://doi.org/10.1159/000099088
Westemeyer, M., Saucier, J., Wallace, J., Prins, S. A., Shetty, A., Malhotra, M., Demko, Z. P., Eng, C. M., Weckstein, L., Boostanfar, R., Rabinowitz, M., Benn, P., Keen-Kim, D., & Billings, P. (2020). Clinical experience with carrier screening in a general population: Support for a comprehensive pan-ethnic approach. Genetics in Medicine, 22(8), 1320-1328. https://doi.org/10.1038/s41436-020-0807-4
Wilkinson, J., Aguilar, S., Neitzel, D., Mitchell, A., Namaroff, S., Faulkner, N., & Aradhya, S. (2020). Evaluating variant reclassification in reproductive carrier screening [conference presentation]. ASHG virtual meeting. https://view.publitas.com/invitae-6xkkz7rlqe79/invitae_ashg2020_faulkner/page/2
World Health Organization. (n.d.). Infertility is a global public health issue. https://www.who.int/reproductivehealth/topics/infertility/perspective/en/
Yao, R., & Goetzinger, K. R. (2016). Genetic carrier screening in the twenty-first century. Clinics in Laboratory Medicine, 36(2), 277-288. https://doi.org/10.1016/j.cll.2016.01.003